Supporting innovation and transformation in the healthcare sector
Life sciences companies operate in an environment shaped by accelerating scientific innovation, the development of health technologies, artificial intelligence and the growing strategic importance of health data.
They also face major industrial challenges — resource availability, healthcare sovereignty, competitiveness and the transformation of production chains — within a complex and constantly evolving regulatory framework.
We advise life sciences companies and healthcare organisations on their development projects, the transformation of innovation into health products or services, and their adaptation to regulatory change and production constraints.
Practical legal support for innovation and industrial performance
We support our clients in securing their projects, facilitating their development and providing the legal and regulatory input required for strategic decisions at every stage of the lifecycle of healthcare products and services. In a sector where regulatory, technological and industrial issues are closely intertwined, we build solutions adapted to the operational realities and development objectives of each organisation.
Our clients include pharmaceutical companies, biotech and medtech companies, CROs, CDMOs, medical device and in vitro diagnostic medical device manufacturers, digital health companies, healthcare institutions, diagnostic laboratories, home healthcare providers and research organisations.
Areas of practice
- Regulation of products, including medicines, medical devices and in vitro diagnostic medical devices, and healthcare activities
- Contractual relations with CDMOs and contract manufacturers
- Pre-clinical and clinical research, related regulation and CRO relationships
- Market access, pricing and reimbursement
- Healthcare promotion, advertising and communications
- Transparency and anti-gift rules
- Digital health, telemedicine and health applications
- Health data, personal health data and data governance
- AI in healthcare
- Research contracts and scientific partnerships
- Regulatory compliance and regulatory litigation
A coordinated cross-practice approach
Life sciences projects involve scientific, technological, regulatory, intellectual property, financing and data-management issues at the same time. We mobilise the firm’s complementary expertise in IP/IT, data protection, M&A, finance, public law and litigation in order to provide coordinated support on the most complex matters.
The firm regularly handles multi-jurisdictional projects and transactions and relies on the Meritas international network for cross-border coordination.
Long-term client relationships
Scientific advances, regulatory developments and industrial constraints continually reshape the conditions for market access, production and innovation.
We support our clients over the long term in order to anticipate these developments and adapt legal and regulatory strategies to the operational realities of their activities.
This close relationship allows us to deliver pragmatic, responsive advice directly tailored to the realities of each player in the healthcare ecosystem.
Our commitment as lawyers
Our commitment as lawyers means supporting healthcare-sector players in projects where scientific innovation, health technologies, industrial challenges, regulatory constraints and human considerations are closely connected.
Securing these transformations means enabling our clients to develop sustainable, responsible healthcare solutions adapted to the evolution of a sector in constant change.
Recognition
